ACONW Company Profile and Key Details

Aclarion, Inc. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended August 06, 2026, missed forecasts by 6.67%. The prior quarter beat by -13.55%. Over the last six quarters, Apple has recorded several small beats. These include 105.37% in May 15, 2025.

ACONW has shown weak momentum, losing -28.78% over the past week and -65.62% over the past quarter, though year-to-date performance is down -92.53%. Average 10-day trading volume of 7.39 thousand shares is below the 3-month average of 34.97 thousand, indicating normal recent market interest.

Aclarion, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.08. This means the shares are trading below this model’s fair value.

Aclarion, Inc. (NASDAQ:ACONW) closed at $0.03 USD, losing -$0.01 (-19.56%) from the previous close of $0.03. The stock is currently trading near its 52-week low $0.03 and $0.05. With a market capitalization of about $13.60 thousand, Aclarion, Inc. is classified as a micro-cap and shows market-like volatility (beta ~1.21). Key stats such as the average daily volume over the past year has been around 25.34 thousand shares, volume is running light vs its 52-week average. Headquartered in Broomfield, CA, Aclarion, Inc. operates in the Healthcare sector and the Medical - Healthcare Information Services industry. Led by CEO Brent Ness, the company employs approximately 11 people and listed since April 22, 2022. Aclarion, Inc. is a healthcare technology firm specializing in software development for magnetic resonance spectroscopy (MRS) within the U.S.

Aclarion, Inc. trades at a P/E ratio of -0.32, slightly below the S&P 500 average, with a price-to-sales ratio of 15.28 and a price-to-book ratio of 0.35 suggesting the stock is closer to book value. The P/FCF stands at -0.16, also above market averages.

Aclarion, Inc. (NASDAQ:ACONW) shares are down -92.53% year-to-date Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Aclarion, Inc. trading at a premium to the broader market with a P/E of -0.32.

Our AI price prediction model suggests that Aclarion, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 17.65%, with price expected at $0.03 by November 20, 2023, within a range of $0.00 to $0.05